PATENT CLAIM ANALYSIS

Application Number: 16044752
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "106000"]

Abstract:
The present invention relates to compounds that act as pan-Rac inhibitors, compositions including the compounds, and methods of using the compounds. In particular, the compounds are useful for treating certain cancers such as breast cancer.

Claim (Index 2):
A compound of  claim 1  or a pharmaceutically acceptable salt thereof, wherein\n A is C 2-7  alkylene wherein one or more of the methylene groups is optionally replaced with O, N(R b ), C(O), or phenylene; \n D is selected from: \n (i) a 4-7 membered ring optionally containing 1 or 2 heteroatoms independently selected from N and O; wherein said ring optionally contains a C\u2550O; and wherein said ring is optionally substituted with one or more groups selected from halogen, OH, C 1-4  alkoxy, C 1-4  alkyl optionally substituted with one or more halogen atoms, C(O)\u2014R e , phenyl optionally substituted with C 1-4  alkoxy, and a 5 or 6 membered ring containing 1 or 2 heteroatoms independently selected from N and O; \n (ii) \u2014N(R f )(R g ); and \n (iii) \u2014C(O)\u2014O\u2014C 1-4  alkyl; and \n R b  is C 1-4  alkyl.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 95.0
- Lexical Diversity: 1.29032
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10894940', '15266411', '12394072', '15499443', '13822809']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.829635414667715
- 35 USC 102 Novelty (BERT): 0.5313637081752659
- Combined Prediction Score: 0.7998082440184702
- Mean Citation Score: 354.313954
- Max Citation Score: 371.0986
- Similarity Product: 274.47255485601426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test